Early effectivity of dupilumab in patients with t2 severe asthma: a prospective real-life study. Castilla-Martinez M, Andujar-Espinosa R, Flores-Martin I, Reyes Cotes MH, et al. J Investig Allergol Clin Immunol 2022 Nov 22:0. doi: 10.18176/jiaci.0872.

Read + Share

Amedeo Smart

Independent Medical Education

Castilla-Martinez M, Andujar-Espinosa R, Flores-Martin I, Reyes Cotes MH, et al. Early effectivity of dupilumab in patients with t2 severe asthma: a prospective real-life study. J Investig Allergol Clin Immunol 2022 Nov 22:0. doi: 10.18176/jiaci.0872.
PMID: 36420744